Similar pharmacokinetics and pharmacodynamics of a new biosimilar and reference insulin aspart in healthy Chinese males

Insulin aspart (IAsp) is one of the main therapies used to control blood glucose after a meal. This study aimed to compare the pharmacokinetics (PK) and pharmacodynamics (PD) of 2 rapid-acting IAsp products: a new IAsp biosimilar (RD10046) and NovoRapid. In a single-center, randomized, single-dose,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Yu, Hongling, Sun, Lisi, Qiao, Jingtao, Wan, Sainan, Li, Shuang, Li, Jiaqi, Tan, Huiwen, Yu, Yerong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096952/
https://www.ncbi.nlm.nih.gov/pubmed/33947913
http://dx.doi.org/10.1038/s41598-021-88782-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096952/
https://www.ncbi.nlm.nih.gov/pubmed/33947913
http://dx.doi.org/10.1038/s41598-021-88782-8

Ejemplares similares